Related Posts
Incannex Engages Catalent for Development and cGMP Manufacture of Psilocybin Drug Product for Clinical Trials and Potential Commercial Use
HTG ACTIVITIES REPORT – JUNE QUARTER 2020
Incannex appoints EAS Advisors LLC to facilitate introductions to US banks and institutions with the intention to list on a US main market
